< BACK TO THE MEMBER DIRECTORY

Forest Laboratories Inc
Mr Rick Overton
500 Commack Road
Commack, NY 11725

Business Focus

Forest Laboratoryes is a U.S. based pharmaceutical company dedicated to identifying,developing, and delivering products that make a positive difference in people's lives. Forest Laboratories' growing product line includes Lexapro(R) (escitalopram oxalate), an SSRI indicated for adults for the initial and maintenance treatment of major depressive disorder and generalized anxiety disorder; Namenda(R) (memantine HCI), an N-methyl-D-asparatate (NMDA)- receptor antagonist indicated for the treatment of moderate to severe Alzheimer's disease; Campral(R)* (acamprostrate calcium), indicated in combination with psychosocial support for the maintenance of abstinence from alcohol in patients with alcohol dependence who are abstinent at treatment initiation; and Bystolic (TM) (nebivolol), a beta-adrenergic receptor blocking agent indicated for the treatment of hypertension. In addition to our growing product line, Forest also co-promotes the Daiichi Sankyo,Inc. product Azor(TM)* (amlodipine and olmesartan medoxomil), a calcium channel blocker and angiotensin receptor blocker combination product indicated for the treatment of hypertension. (*Azor is a trademark of Daiichi Sankyo, Inc. and Campral is a registered trademark of Merck Sante s.a.s., a subsidiary of Merck KGaA, Darmstadt, Germany.)


Company Statement

Based in New York City with operations on Long Island, New Jersey, Missouri, Ohio, Ireland and the U.K. and a national U.S. salesforce, Forest has approximately 5,000 employees and currently ranks among the top 15 U.S. pharmaceutical companies. On Long Island, Forest employs more than 750 people at multiple locations in several key functional areas, including Packaging, Informatics (IT), Sales Training & Leadership Development, and Pharmaceutical Research and Development. The Company's scientific division utilizes state-of-the art technology and an experienced and talented workforce to develop innovative products that improve people's lives everyday. These capabilities enable Forest to license compounds at any stage - from preclinical to products that are ready for FDA review - then complete the regulatory work to successfully bring these new products to market.

For more information, visit www.frx.com